SOAP Note Example for Hypertension Patient
A comprehensive SOAP note for a hypertensive patient should include detailed assessment of cardiovascular risk factors and a clear treatment plan targeting blood pressure <130/80 mmHg using guideline-recommended medications and lifestyle modifications.
Subjective
- Chief complaint: "My blood pressure has been running high lately" or "I'm here for my blood pressure check"
- History of present illness:
- Duration of hypertension
- Current symptoms (headache, dizziness, visual changes, chest pain, shortness of breath)
- Home blood pressure readings and monitoring frequency
- Current antihypertensive medications and adherence
- Recent medication changes
- Lifestyle factors (diet, exercise, salt intake, alcohol consumption)
- Past medical history:
- Cardiovascular disease (coronary artery disease, heart failure, stroke, peripheral artery disease)
- Diabetes mellitus
- Chronic kidney disease
- Hyperlipidemia
- Sleep apnea
- Family history:
- Hypertension, cardiovascular disease, sudden cardiac death
- Social history:
- Smoking status
- Alcohol intake
- Physical activity level
- Dietary habits (salt intake, DASH or Mediterranean diet adherence)
- Stress levels
- Occupation
- Review of systems:
- Cardiovascular: chest pain, palpitations, edema
- Neurological: headache, dizziness, vision changes
- Renal: polyuria, nocturia, hematuria
Objective
- Vital signs:
- Blood pressure (both arms, seated position after 5 minutes rest)
- Heart rate
- Respiratory rate
- Temperature
- Height, weight, BMI
- Physical examination:
- General appearance
- Cardiovascular: heart sounds, murmurs, jugular venous distention
- Pulmonary: breath sounds, crackles
- Extremities: peripheral pulses, edema
- Neurological: mental status, focal deficits
- Fundoscopic examination (if BP >180/110 mmHg) 1
- Laboratory data:
- Comprehensive metabolic panel (electrolytes, renal function)
- Lipid panel
- Urinalysis (protein, blood)
- Urine albumin-to-creatinine ratio 1
- Hemoglobin A1c (if diabetic or at risk)
- Diagnostic studies:
Assessment
- Hypertension classification (based on 2024 ESC Guidelines) 1:
- Normal BP: <120/80 mmHg
- Elevated BP: 120-139/70-89 mmHg
- Hypertension: ≥140/90 mmHg
- Hypertension severity:
- Stage 1: 140-159/90-99 mmHg
- Stage 2: ≥160/100 mmHg
- Hypertensive emergency if BP ≥180/110 mmHg with evidence of acute target organ damage 1
- Cardiovascular risk assessment:
- SCORE2 or SCORE2-OP risk calculation for patients 40-69 years or ≥70 years respectively 1
- Target organ damage evaluation (heart, kidneys, eyes, brain)
- 10-year cardiovascular disease risk assessment
- Secondary causes of hypertension (if suspected)
- Medication adherence assessment
- Lifestyle factors contributing to hypertension
Plan
- Blood pressure goal: <130/80 mmHg (for most patients, especially those with diabetes, CKD, or established cardiovascular disease) 1, 2
- Pharmacological therapy:
- First-line medications: thiazide/thiazide-like diuretics, ACE inhibitors, ARBs, or calcium channel blockers 2
- For non-Black patients: start with ACE inhibitor (e.g., lisinopril 10 mg daily) or ARB (e.g., losartan 50 mg daily) 2, 3, 4
- For Black patients: start with calcium channel blocker (e.g., amlodipine 5 mg daily) or thiazide diuretic 2, 5
- Combination therapy if BP >20/10 mmHg above goal 2
- Avoid combination of ACE inhibitors and ARBs due to increased risk of hyperkalemia 2
- Laboratory monitoring:
- Lifestyle modifications:
- Follow-up:
- Return visit in 2-4 weeks for medication adjustment if starting new therapy
- Home blood pressure monitoring with log
- Once controlled, follow-up every 3-6 months 2
- Patient education:
- Explanation of hypertension risks and complications
- Medication instructions and potential side effects
- Home blood pressure monitoring technique
- Lifestyle modification strategies
- Warning signs of hypertensive emergency
Special Considerations
- For hypertensive emergencies (BP ≥180/110 mmHg with acute organ damage):
- For resistant hypertension (BP ≥130/80 mmHg despite 3+ medications including a diuretic):